Cargando…

Structural and Functional Overview of TEAD4 in Cancer Biology

TEA domain transcription factor 4 (TEAD4) is an important member of the TEAD family. As a downstream effector of the Hippo pathway, TEAD4 has essential roles in cell proliferation, cell survival, tissue regeneration, and stem cell maintenance. TEAD4 contains a TEA DNA binding domain that binds the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Mu, Huang, Bingsong, Zhu, Lei, Chen, Kui, Liu, Min, Zhong, Chunlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547805/ https://www.ncbi.nlm.nih.gov/pubmed/33116572 http://dx.doi.org/10.2147/OTT.S266649

Ejemplares similares

RECQ1 Promotes Stress Resistance and DNA Replication Progression Through PARP1 Signaling Pathway in Glioblastoma
por: Zhang, Jing, et al.
Publicado: (2021)

Genomic Analysis Uncovers Immune Microenvironment Characteristics and Drug Sensitivity of Ferroptosis in Breast Cancer Brain Metastasis
por: Zhu, Lei, et al.
Publicado: (2022)

Regulation of TEAD Transcription Factors in Cancer Biology
por: Huh, Hyunbin D., et al.
Publicado: (2019)

VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle
por: Figeac, Nicolas, et al.
Publicado: (2019)

TEAD4 as an Oncogene and a Mitochondrial Modulator
por: Hsu, Sheng-Chieh, et al.
Publicado: (2022)

Multifaceted function of YAP/TEAD on chromatin:prospects of ‘A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer’
por: Chen, Lizhen, et al.
Publicado: (2019)

Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex
por: Kaan, Hung Yi Kristal, et al.
Publicado: (2017)

Repurposing of Drugs Targeting YAP-TEAD Functions
por: Elisi, Gian Marco, et al.
Publicado: (2018)

Flap endonuclease 1 and DNA-PKcs synergistically participate in stabilizing replication fork to encounter replication stress in glioma cells
por: Zhang, Jing, et al.
Publicado: (2022)

TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma
por: Wang, Ya-Qin, et al.
Publicado: (2023)

CK2-induced cooperation of HHEX with the YAP-TEAD4 complex promotes colorectal tumorigenesis
por: Guo, Yuegui, et al.
Publicado: (2022)

DNA Damage Response Evaluation Provides Novel Insights for Personalized Immunotherapy in Glioma
por: Chen, Mu, et al.
Publicado: (2022)

Gatekeepers of pancreas: TEAD and YAP
por: Rodríguez-Seguí, Santiago A., et al.
Publicado: (2015)

Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive YAP/TAZ–TEAD Biosensors
por: Nouri, Kazem, et al.
Publicado: (2019)

Arginine is an epigenetic regulator targeting TEAD4 to modulate OXPHOS in prostate cancer cells
por: Chen, Chia-Lin, et al.
Publicado: (2021)

TEAD4 antagonizes cellular senescence by remodeling chromatin accessibility at enhancer regions
por: Zhang, Donghui, et al.
Publicado: (2023)

VGLL4 and MENIN function as TEAD1 corepressors to block pancreatic β cell proliferation
por: Li, Feng, et al.
Publicado: (2023)

VGLL4 targets a TCF4–TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer
por: Jiao, Shi, et al.
Publicado: (2017)

The role of lysine palmitoylation/myristoylation in the function of the TEAD transcription factors
por: Mesrouze, Yannick, et al.
Publicado: (2022)

TEADs serve as potential prognostic biomarkers and targets for human gastric cancer
por: Wang, Meng-huan, et al.
Publicado: (2022)

Nuclear TEAD4 with SIX1 Overexpression is an Independent Prognostic Marker in the Stage I–III Colorectal Cancer
por: Yu, Tong, et al.
Publicado: (2021)

Hippo/TEAD4 signaling pathway as a potential target for the treatment of breast cancer
por: Wu, Yujian, et al.
Publicado: (2021)

VGLL4 promotes osteoblast differentiation by antagonizing TEADs-inhibited Runx2 transcription
por: Suo, Jinlong, et al.
Publicado: (2020)

PHF5A promotes colorectal cancerprogression by alternative splicing of TEAD2
por: Chang, Yue, et al.
Publicado: (2021)

Tead1 is required for perinatal cardiomyocyte proliferation
por: Liu, Ruya, et al.
Publicado: (2019)

TEAD4 is a novel independent predictor of prognosis in LGG patients with IDH mutation
por: Yuan, Hai-Yan, et al.
Publicado: (2021)

TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer
por: Chi, Ming, et al.
Publicado: (2022)

The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis
por: Zhou, Yuhang, et al.
Publicado: (2016)

Emerging roles of TEAD transcription factors and its coactivators in cancers
por: Pobbati, Ajaybabu V., et al.
Publicado: (2013)

A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy
por: Pobbati, Ajaybabu V., et al.
Publicado: (2020)

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
por: Cunningham, Richard, et al.
Publicado: (2022)

Two machine learning methods identify a metastasis-related prognostic model that predicts overall survival in medulloblastoma patients
por: Chen, Kui, et al.
Publicado: (2020)

G-quadruplexes formation within the promoter of TEAD4 oncogene and their interaction with Vimentin
por: Cozzaglio, Marta, et al.
Publicado: (2022)

TEAD4 as a Prognostic Marker Promotes Cell Migration and Invasion of Urinary Bladder Cancer via EMT
por: Huang, Zhengnan, et al.
Publicado: (2021)

Analysis in silico of the functional interaction between WNT5A and YAP/TEAD signaling in cancer
por: Astudillo, Pablo
Publicado: (2021)

Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors
por: Holden, Jeffrey K., et al.
Publicado: (2018)

Exploring trophoblast-specific Tead4 enhancers through chromatin conformation capture assays followed by functional screening
por: Tomikawa, Junko, et al.
Publicado: (2020)

Epigenetic silencing of miR‐1271 enhances MEK1 and TEAD4 expression in gastric cancer
por: Lim, Byungho, et al.
Publicado: (2018)

YAP inhibits ERα and ER(+) breast cancer growth by disrupting a TEAD-ERα signaling axis
por: Li, Xu, et al.
Publicado: (2022)

The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27(Kip1)
por: Wang, Chunyan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hpvc2f13gl7k6j71gldofuem1q